DICYCLOBUTYLAMINE HCL
|
- $45 - $60000
- Product name: DICYCLOBUTYLAMINE HCL
- CAS: 90203-81-9
- MF: C8H16ClN
- MW: 161.67
- EINECS:
- MDL Number:MFCD11844782
- Synonyms:Dicyclobutylamine hydrochloride;DICYCLOBUTYLAMINE HCL;N-Cyclobutylcyclobutanamine hydrochloride;Dicyclobutylamine x HCl, 98%
5 prices
Selected condition：
Brand
- A1 Biochem Labs
- Crysdot
- SynQuest Laboratories
- TRC
Package
- 10mg
- 250mg
- 1g
- 5g
- 10g
- ManufacturerA1 Biochem Labs
- Product number6564670
- Product descriptionDicyclobutylaminehydrochloride 95%
- Packaging10g
- Price$1200
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD13001663
- Product descriptionDicyclobutylaminehydrochloride 95+%
- Packaging5g
- Price$814
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number3231-5-02
- Product descriptionN-Cyclobutylcyclobutanamine hydrochloride 98.0%
- Packaging250mg
- Price$126
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number3231-5-02
- Product descriptionN-Cyclobutylcyclobutanamine hydrochloride 98.0%
- Packaging1g
- Price$404
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD439683
- Product descriptionDicyclobutylamineHydrochloride
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| A1 Biochem Labs | 6564670 | Dicyclobutylaminehydrochloride 95% | 10g | $1200 | 2021-12-16 | Buy |
| Crysdot | CD13001663 | Dicyclobutylaminehydrochloride 95+% | 5g | $814 | 2021-12-16 | Buy |
| SynQuest Laboratories | 3231-5-02 | N-Cyclobutylcyclobutanamine hydrochloride 98.0% | 250mg | $126 | 2021-12-16 | Buy |
| SynQuest Laboratories | 3231-5-02 | N-Cyclobutylcyclobutanamine hydrochloride 98.0% | 1g | $404 | 2021-12-16 | Buy |
| TRC | D439683 | DicyclobutylamineHydrochloride | 10mg | $45 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|